RBX1 and Miyoshi myopathy: To further confirm the hypothesis that MM cells with RBX1 suppression are less sensitive to the cytotoxicity of chemotherapeutics, we treated cells with mitoxantrone (2 μM) or melphalan (10 μM) for 48 h.